Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

HMBi supplementation boosts cashmere growth by affecting specific metabolic and signaling pathways in goats.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

A surface with VEGF can specifically capture endothelial cells from flowing fluids.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Micro-Imager® helps see how drugs spread in human skin.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Standardized guidelines are needed to improve drug-loaded extracellular vesicle purification.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

A new fluorescent material can detect dextran sulfate sodium, turning green when present, useful for forensic and environmental monitoring.

Capillary microfluidic wearables are promising for non-invasive health monitoring through sweat and saliva.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

AI-enhanced smart patches can personalize drug delivery for better treatment outcomes.

A new non-invasive laser system improves chronic disease management and metabolic health.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Droplet microfluidics can precisely create microgels for advanced bioengineering uses.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Using blood-based implants improves skin healing and reduces scarring.

Microfluidic models improve testing for aging, wound healing, and oral tissue, reducing animal testing.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Droplet microfluidics improves efficiency and control in chemistry, biology, and nanotechnology.